Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish AnalystBenzinga • 04/11/25
Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare ConferencePRNewsWire • 04/03/25
Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection TechnologyPRNewsWire • 03/27/25
Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/24/25
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial ResultsPRNewsWire • 03/24/25
Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer ScreeningPRNewsWire • 03/20/25
Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed PublicationPRNewsWire • 03/18/25
Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA TestPRNewsWire • 03/13/25
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025PRNewsWire • 03/10/25
Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERDPRNewsWire • 02/27/25
Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferencePRNewsWire • 02/06/25
Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RulePRNewsWire • 12/23/24
Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for FirefightersPRNewsWire • 12/19/24
Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed PublicationPRNewsWire • 12/11/24
Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term MilestonesPRNewsWire • 12/03/24
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA TestPRNewsWire • 11/20/24
Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumPRNewsWire • 11/18/24